Synergy Pharma (SGYP) Misses Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts SGYP Hot Sheet
Join SI Premium – FREE
Synergy Pharma (NASDAQ: SGYP) reported Q2 EPS of ($0.34), $0.06 worse than the analyst estimate of ($0.28).
For earnings history and earnings-related data on Synergy Pharma (SGYP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is Treasury selloff a major issue for stock market bulls?
- INVO Fertility (IVF) Tops Q2 EPS by 105c
- Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
